载脂蛋白B水平在LDL-C或非HDL-C谱系中的个体差异
现行指南仅对高甘油三酯者检测apoB的策略可能过窄,人群百分位数据可用于将LDL-C目标转换为apoB等效值。
要点
- LDL-C为100 mg/dL时,apoB的95%人群分布为66-99 mg/dL,个体差异明显。
- 代谢健康人群中仍可见apoB与LDL-C不一致,仅高甘油三酯者检测apoB可能过窄。
- 人群百分位数据有助于将LDL-C目标转换为apoB等效值。
核心结论
- 即使代谢健康个体也可能出现apoB相对于LDL-C或非HDL-C不一致性升高。
- 现行指南仅对高甘油三酯者检测apoB的策略似乎过窄。
- 人群百分位数据可用于将LDL-C目标与阈值转换为apoB等效值以促进临床采用。
研究设计与样本
- 横断面研究,使用2005-2016年美国国家健康与营养调查(NHANES)全国代表性样本。
- 采用分位数回归评估apoB在LDL-C或非HDL-C水平上的人群分布。
主要发现
- LDL-C为55、70、100、190 mg/dL时,对应的人群apoB中位数分别为49、60、80、140 mg/dL。
- LDL-C为100 mg/dL时,apoB的95%人群分布范围为66 mg/dL至99 mg/dL。
- apoB变异性在使用Friedewald方程估算LDL-C时最高,使用Sampson或Martin-Hopkins方程时较低,非HDL-C时最低。
- 具有代谢危险因素者更可能出现apoB不一致性升高,但代谢健康个体中仍观察到显著apoB变异性。
临床怎么用
- 临床可参考人群百分位数据将LDL-C目标转换为apoB等效值。
- 不应仅局限于高甘油三酯患者检测apoB,代谢健康者也可能存在apoB不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although apolipoprotein B (apoB) is a superior marker of lipid-related risk compared with low-density lipoprotein cholesterol (LDL-C), few data exist to translate the goals and thresholds from LDL-C to their apoB equivalent. In addition, although current American College of Cardiology/American Heart Association guidelines provide a relative indication for apoB measurement among individuals with hypertriglyceridemia, whether discordance is limited to those subgroups is unknown. OBJECTIVES: To assess the variability in apoB level across the spectrum of LDL-C or non-high-density lipoprotein cholesterol (non-HDL-C) levels and evaluate whether discordance between apoB and LDL-C or non-HDL-C is limited to specifiable subgroups. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from a nationally representative sample of 12 688 adult participants not using statins in the National Health and Nutrition Examination Survey between 2005 and 2016. Statistical analysis was performed from April 2023 to February 2024. MAIN OUTCOMES AND MEASURES: Quantile regression was used to assess the population distribution of apoB across LDL-C or non-HDL-C levels. Discordance between apoB and LDL-C was the difference between measured apoB and median apoB levels for an individual's LDL-C level. Discordance was evaluated by age, sex, race and ethnicity, obesity, diabetes, triglyceride level, hemoglobin A1c level, body mass index (BMI), statin use, and metabolic health (defined as a BMI between 18.5 and 24.9, triglyceride level <150 mg/dL, and no diabetes). RESULTS: Among the sample of 12 688 participants (median age, 41.0 years [IQR, 29.0-54.0 years]; 52.9% women) for LDL-C values of 55, 70, 100, and 190 mg/dL, the corresponding population median apoB levels were 49, 60, 80, and 140 mg/dL, respectively. For given levels of LDL-C, a range of apoB values was observed. At an LDL-C level of 100 mg/dL, the 95% population distribution of apoB ranged from 66 mg/dL to 99 mg/dL. ApoB variability was highest for LDL-C values estimated using the Friedewald equation, lower when using Sampson or Martin-Hopkins equations, and lowest for non-HDL-C. Although individuals with metabolic risk factors were more likely to have discordantly high apoB levels (ie, had higher median observed apoB levels relative to what was estimated based on LDL-C), significant variability in apoB levels was observed even among metabolically healthy individuals. CONCLUSIONS AND RELEVANCE: This study suggests that even metabolically healthy individuals may have discordantly high apoB levels relative to LDL-C or non-HDL-C levels. The current guideline approach for apoB testing only for those with hypertriglyceridemia appears too narrow. Population percentile data can be used to translate LDL-C goals and thresholds to their apoB equivalent to facilitate clinical adoption.
引用
- Sayed A, Peterson ED, Virani SS, et al. Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024. PMID: 38865115. doi:10.1001/jamacardio.2024.1310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。